Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;15(11):1540-5, i.
doi: 10.5588/ijtld.10.0273.

Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales

A M Kipp  1 , P Pungrassami, P W Stewart, V Chongsuvivatwong, R P Strauss, A Van Rie
Affiliations

Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales

A M Kipp et al. Int J Tuberc Lung Dis. 2011 Nov.

Abstract

Background: Adherence to tuberculosis (TB) treatment is important for TB control. The effect of stigma on adherence has not been well quantified.

Objective: To identify the effects of TB and acquired immune-deficiency syndrome (AIDS) stigma on missed doses during TB treatment.

Design: Validated TB and AIDS stigma scales assessing perceived and experienced/felt stigma were administered in a prospective cohort of 459 TB patients at TB treatment initiation and after 2 months. Repeated measures and multivariable models estimated the effects of stigma on the rate of missed doses.

Results: Fifty-six per cent of patients missed no doses, and associations between stigma and missed doses were minimal. Heterogeneity of effects was observed, how- ever, with higher experienced and felt TB stigma increasing missed doses among women (adjusted RR 1.22, 95%CI 1.10-1.34) and human immunodeficiency virus (HIV) co-infected patients (aRR 1.39, 95%CI 1.13-1.72). Experienced and felt AIDS stigma also increased missed doses among HIV co-infected patients (aRR 1.43, 95%CI 1.31-1.56).

Conclusion: Stigma has a minimal effect in this population with good adherence. Among women and HIV co-infected patients, however, experienced and felt stigma, and not perceived stigma, increased the rate of missed doses. Further research is needed to determine if stigma or coping interventions among these subgroups would improve adherence.

PubMed Disclaimer

Comment in

  • Measuring stigma: are we looking in the right places?
    Zetola NM, Olabiyi B, Ramogola-Masire D, Modongo C. Zetola NM, et al. Int J Tuberc Lung Dis. 2012 Aug;16(8):1130-1. doi: 10.5588/ijtld.11.0824. Int J Tuberc Lung Dis. 2012. PMID: 22762427 Free PMC article. No abstract available.

References

    1. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet. 2003 Sep 13;362(9387):887–99. - PubMed
    1. WHO. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva: World Health Organization; 2003. Contract No.: WHO/CDS/TB/2003.313.
    1. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998 Mar 25;279(12):943–8. - PubMed
    1. Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV, et al. Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bulletin of the World Health Organization. 2007 Sep;85(9):703–11. - PMC - PubMed
    1. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Medicine. 2007 Jul 24;4(7):e238. - PMC - PubMed

Publication types

MeSH terms